Fertility Preservation in Patients with Endometrial Cancer - European Medical Journal

Fertility Preservation in Patients with Endometrial Cancer

Reproductive Health
Download PDF
*Hasan Onur Topçu, Zeynep Aslı Oskovi, Mehmet Mutlu Meydanlı

The authors have declared no conflicts of interest.

EMJ Repro Health. ;1[1]:81-86. DOI/10.33590/emjreprohealth/10310789. https://doi.org/10.33590/emjreprohealth/10310789.
conservative treatment, endometrial cancer, Fertility Preservation, fertility sparing, progestin

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


Endometrial carcinoma (EC) is the most common gynaecological cancer, with 2-14% of cases occurring in women <40 years of age. When considering the increase in the delay of pregnancy in developing countries, the incidence of EC in nulliparous women is likely to increase. Younger women with EC have a chance to preserve their fertility due to the probability of being diagnosed with early-stage and low- grade endometrioid carcinomas. However, it should be noted that the most important step of fertility preservation in patients with EC is patient selection. The appropriate clinical criteria should include: a) well-differentiated histology; b) absence of myometrial invasion; c) absence of extrauterine or pelvic and pre-aortic lymphatic spread; and d) absence of synchronous ovarian tumour. There is no consensus regarding endometrial suppression therapy or the follow-up period for fertility preservation in women with EC. Therefore, this review aims to evaluate the current literature.

Please view the full content in the PDF above. 

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now